These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 10431559

  • 21. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma.
    Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, Erle DJ.
    Nat Med; 2002 Aug; 8(8):885-9. PubMed ID: 12091879
    [Abstract] [Full Text] [Related]

  • 22. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM, Xie QM, Tang HF, Sun JG, Deng JF, Chen JQ, Yang SY.
    Eur J Pharmacol; 2006 Oct 10; 547(1-3):125-35. PubMed ID: 16956605
    [Abstract] [Full Text] [Related]

  • 23. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
    Ram A, Mabalirajan U, Singh SK, Singh VP, Ghosh B.
    Int Immunopharmacol; 2008 Jun 10; 8(6):893-9. PubMed ID: 18442795
    [Abstract] [Full Text] [Related]

  • 24. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
    Cho YS, Kwon B, Lee TH, Kim TB, Moon KA, La S, Lee J, Lee SD, Oh YM, Moon HB.
    Clin Exp Allergy; 2006 Mar 10; 36(3):377-85. PubMed ID: 16499650
    [Abstract] [Full Text] [Related]

  • 25. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study.
    Hirota JA, Ask K, Fritz D, Ellis R, Wattie J, Richards CD, Labiris R, Kolb M, Inman MD.
    Clin Exp Allergy; 2009 Jan 10; 39(1):147-58. PubMed ID: 19032363
    [Abstract] [Full Text] [Related]

  • 26. Adenosine in the airways: implications and applications.
    Spicuzza L, Di Maria G, Polosa R.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):77-88. PubMed ID: 16458886
    [Abstract] [Full Text] [Related]

  • 27. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
    Fullmer JJ, Khan AM, Elidemir O, Chiappetta C, Stark JM, Colasurdo GN.
    Pediatr Allergy Immunol; 2005 Nov 08; 16(7):593-601. PubMed ID: 16238585
    [Abstract] [Full Text] [Related]

  • 28. [Airway myocytes as immune effector cells in the pathogenesis of bronchial asthma. Myocyte culture as an in vitro model].
    John M, Hirst SJ, Chung KF, Witt C.
    Pneumologie; 1999 Jun 08; 53(6):302-6. PubMed ID: 10431558
    [No Abstract] [Full Text] [Related]

  • 29. Inflammation: its clinical relevance in airway diseases. Proceedings of an international symposium. Amsterdam, 16-17 March 1986.
    Eur J Respir Dis Suppl; 1986 Jun 08; 147():1-345. PubMed ID: 3021485
    [No Abstract] [Full Text] [Related]

  • 30. The mechanics of the expiration evaluated by a model.
    Pedersen OF.
    Acta Physiol Scand Suppl; 1973 Jun 08; 386():1-26. PubMed ID: 4521067
    [No Abstract] [Full Text] [Related]

  • 31. The leukotrienes: mediators of chronic inflammation in asthma.
    Sampson AP.
    Clin Exp Allergy; 1996 Sep 08; 26(9):995-1004. PubMed ID: 8889256
    [No Abstract] [Full Text] [Related]

  • 32. [Airway inflammation in asthma].
    Fukuda T.
    Nihon Naika Gakkai Zasshi; 1996 Feb 10; 85(2):189-93. PubMed ID: 8708445
    [No Abstract] [Full Text] [Related]

  • 33. Location of airway inflammation in asthma and the relationship to circadian change in lung function.
    Martin RJ.
    Chronobiol Int; 1999 Sep 10; 16(5):623-30. PubMed ID: 10513885
    [Abstract] [Full Text] [Related]

  • 34. Tachykinins and airway function.
    Lagente V, Advenier C.
    Pulm Pharmacol Ther; 1998 Sep 10; 11(5-6):331-40. PubMed ID: 10210651
    [No Abstract] [Full Text] [Related]

  • 35. Animal models of bronchial hyperreactivity.
    Emala C, Hirshman C.
    Monogr Allergy; 1996 Sep 10; 33():35-52. PubMed ID: 8930925
    [No Abstract] [Full Text] [Related]

  • 36. [The new insight into the pathogenic unity of the upper and lower airways].
    Mroczkowski E, Wielgosz R.
    Otolaryngol Pol; 2008 Sep 10; 62(1):31-6. PubMed ID: 18637418
    [Abstract] [Full Text] [Related]

  • 37. The epithelium as a target of glucocorticoid action in the treatment of asthma.
    Schwiebert LM, Stellato C, Schleimer RP.
    Am J Respir Crit Care Med; 1996 Aug 10; 154(2 Pt 2):S16-9; discussion S19-20. PubMed ID: 8756782
    [No Abstract] [Full Text] [Related]

  • 38. Animal models of airway hyperresponsiveness.
    Said SI.
    Eur Respir J; 2009 Jan 10; 33(1):217-8. PubMed ID: 19118233
    [No Abstract] [Full Text] [Related]

  • 39. Lung parenchymal shear modulus, airway wall remodeling, and bronchial hyperresponsiveness.
    Lambert RK, Paré PD.
    J Appl Physiol (1985); 1997 Jul 10; 83(1):140-7. PubMed ID: 9216956
    [Abstract] [Full Text] [Related]

  • 40. Mouse models of airway responsiveness: physiological basis of observed outcomes and analysis of selected examples using these outcome indicators.
    Drazen JM, Finn PW, De Sanctis GT.
    Annu Rev Physiol; 1999 Jul 10; 61():593-625. PubMed ID: 10099703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.